Form 20-F NOVARTIS AG For: Dec 31
http://archive.fast-edgar.com/20260204/APBDB22CG222D2Z2222Q22ZZ8BEGZ2G23282
Filed on: February 4, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Novartis drug Rhapsido for symptomatic dermographism
- Novartis (NOVN:SW) (NVS) PT Lowered to CHF130 at Morgan Stanley
- BioMedNewsBreaks — Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) to Host Investor Presentation Highlighting Depression and Anxiety Treatment Programs on Oct. 21
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share